Bank Of New York Mellon Corp Ligand Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $9.68 Million - $15.2 Million	156,833 New	156,833 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $21 - $227,704	-2,117 Reduced 1.29%	162,545 $14 Million
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $1.45 Million - $2.27 Million	-19,406 Reduced 10.54%	164,662 $14.7 Million
Q1 2022 May 11, 2022	SELL	$94.99 - $151.56 $721,639 - $1.15 Million	-7,597 Reduced 3.96%	184,068 $20.7 Million
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $389,582 - $506,008	3,051 Added 1.62%	191,665 $29.6 Million
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $139,373 - $197,122	-1,362 Reduced 0.72%	188,614 $26.3 Million
Q2 2021 Aug 11, 2021	BUY	$113.03 - $155.64 $1.06 Million - $1.46 Million	9,396 Added 5.2%	189,976 $24.9 Million
Q1 2021 May 13, 2021	SELL	$99.52 - $215.83 $1.64 Million - $3.57 Million	-16,524 Reduced 8.38%	180,580 $27.5 Million
Q4 2020 Feb 09, 2021	SELL	$80.55 - $106.05 $930,110 - $1.22 Million	-11,547 Reduced 5.53%	197,104 $19.6 Million
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $1.24 Million - $1.75 Million	-13,813 Reduced 6.21%	208,651 $19.9 Million
Q2 2020 Aug 12, 2020	SELL	$68.28 - $123.65 $773,339 - $1.4 Million	-11,326 Reduced 4.84%	222,464 $24.9 Million
Q1 2020 May 06, 2020	SELL	$63.37 - $107.88 $2.08 Million - $3.54 Million	-32,795 Reduced 12.3%	233,790 $17 Million
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $3.33 Million - $3.9 Million	-34,327 Reduced 11.41%	266,585 $27.8 Million
Q3 2019 Nov 07, 2019	SELL	$86.25 - $120.16 $3.64 Million - $5.07 Million	-42,160 Reduced 12.29%	300,912 $30 Million
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $182,975 - $220,395	-1,704 Reduced 0.49%	343,072 $39.2 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $6.63 Million - $8.91 Million	-62,560 Reduced 15.36%	344,776 $43.3 Million
Q4 2018 Feb 11, 2019	SELL	$128.36 - $272.13 $11.7 Million - $24.7 Million	-90,892 Reduced 18.24%	407,336 $55.3 Million
Q3 2018 Nov 09, 2018	SELL	$211.18 - $274.49 $3.49 Million - $4.54 Million	-16,549 Reduced 3.21%	498,228 $0
Q2 2018 Aug 06, 2018	SELL	$150.77 - $207.98 $706,809 - $975,010	-4,688 Reduced 0.9%	514,777 $107 Million
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $962,923 - $1.27 Million	-6,946 Reduced 1.32%	519,465 $85.8 Million
Q4 2017 Feb 09, 2018	BUY	$128.36 - $147.04 $67.6 Million - $77.4 Million	526,411	526,411 $72.1 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account